These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
16. Design and synthesis of 11α-substituted bile acid derivatives as potential anti-tuberculosis agents. Pore VS; Divse JM; Charolkar CR; Nawale LU; Khedkar VM; Sarkar D Bioorg Med Chem Lett; 2015 Oct; 25(19):4185-90. PubMed ID: 26299346 [TBL] [Abstract][Full Text] [Related]
17. Design and synthesis of 1H-1,2,3-triazoles derived from econazole as antitubercular agents. Kim S; Cho SN; Oh T; Kim P Bioorg Med Chem Lett; 2012 Nov; 22(22):6844-7. PubMed ID: 23058885 [TBL] [Abstract][Full Text] [Related]
18. Design, Synthesis, and in vitro antitubercular activity of 1,2,3-triazolyl-dihydroquinoline derivatives. Banu S; Bollu R; Nagarapu L; Nanubolu JB; Yogeswari P; Sriram D; Gunda SK; Vardhan D Chem Biol Drug Des; 2018 Jul; 92(1):1315-1323. PubMed ID: 29624868 [TBL] [Abstract][Full Text] [Related]
19. Synthesis and antitubercular activity of new 1,3,4-oxadiazoles bearing pyridyl and thiazolyl scaffolds. Dhumal ST; Deshmukh AR; Bhosle MR; Khedkar VM; Nawale LU; Sarkar D; Mane RA Bioorg Med Chem Lett; 2016 Aug; 26(15):3646-51. PubMed ID: 27301367 [TBL] [Abstract][Full Text] [Related]
20. 1H-1,2,3-Triazole tethered isatin-moxifloxacin: Design, synthesis and in vitro anti-mycobacterial evaluation. Jiang Y; Qian A; Li Y Arch Pharm (Weinheim); 2019 Jul; 352(7):e1900040. PubMed ID: 31106443 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]